Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
DARMSTADT, Germany, Jan. 7, 2021 /PRNewswire-AsiaNet/ -- - Adds to Merck's lipid manufacturing expertise, providing an integrated offering across mRNA value chain - AmpTec's differentiated polymerase chain reaction (PCR)-based technology has shown to have advantages over other technologies for mRNA ...
Authors: LATEST ASIANET NEWS RELEASES